Prospective observational study of SNIPPV use in preterm infants of less than 32weeks of gestation from January 2012 to December 2015. Previous respiratory status is analyzed as well as respiratory outcomes and possible secondary side effects. SNIPPV is used to prevent Intubation in Infants in which nCPAP has already failed (Infants that met intubation criteria) and also is used electively for extubation when nCPAP extubation has previously failed or infants with Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP \> 10 cmH2O and FiO2\>35%).
SNIPPV is used to prevent Intubation in Infants in which nCPAP has already failed (Infants that met intubation criteria) and also is used electively for extubation when nCPAP extubation has previously failed or infants with Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP \> 10 cmH2O and FiO2\>35%).
Study Type
OBSERVATIONAL
Enrollment
45
Cristina Ramos-Navarro
Madrid, Spain
Avoid of Invasive Mechanical Ventilation in the next three days.
The rate of infants treated with non-invasisive ventilation that do not need to be intubated in the next three days.
Time frame: through study completion, an average of 1 year
Time on MV
Days on MV during hospitalitation
Time frame: through study completion, an average of 1 year
Neurological impairment
Intraventricular hemorrhage grade 3 or 4 (papile´s classification)
Time frame: through study completion, an average of 1 year
Rate of patients with air leaks
pulmonary air leak
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.